Oxidative stress promotes ocular neovascularization

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 544-552

  Dong, Aling ^a   Xie, Bing ^a   Shen, Jikui ^a   Yoshida, Tsunehiko ^a   Yokoi, Katsutoshi ^a   Hackett, Sean F ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; RHODOPSIN; THIOCTIC ACID; VASCULOTROPIN; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRUCH MEMBRANE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RETINA ISCHEMIA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; WILD TYPE; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; ISCHEMIA; METABOLISM; MOUSE MUTANT; RETINA BLOOD VESSEL; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; TRANSGENIC MOUSE;

MUS;

ANIMALS; ANTIOXIDANTS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIA; MACULAR DEGENERATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64549116363     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21698     Document Type: Article

References (27)

1. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417-1436. (Pubitemid 32963246)
2. Al-Shabrawey M, Bartoli M, El-Remessy A, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB. 2008. Role of NADPH oxidase and STAT3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci 49:3231-3238.
3. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, Group AS. 2006. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444. (Pubitemid 44511558)
4. Caldwell RB, Bartoli M, Behzadian RA, El-Remessy AEB, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW. 2005. Vascular endothelial growth factor and diabetic retinopathy: Role of oxidative stress. Curr Drug Targets 6:511-524. (Pubitemid 40916276)
5. Crabb JW, Miyagi M, Gu X, Shadrach K, West K, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. 2002. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natil Acad Sci USA 99:14682-14687. (Pubitemid 35334544)
6. Dong A, Shen J, Krause M, Akiyama H, Hackett SF, Lai H, Campochiaro PA. 2006. Superoxide dismutase 1 protects retinal cells from oxidative damage. J Cell Physiol 208:516-526. (Pubitemid 44141876)
7. Finkel T. 1999. Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65:337-340. (Pubitemid 29109705)
8. Hsu TC, Young MR, Cmarik J, Colburn NH. 2000. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 28:1338-1348. (Pubitemid 30621478)
9. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, Uchiyama S, Shimizu T, Mizushima Y, Shirasawa T, Tsubota K. 2006. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration. Proc Natl Acad Sci USA 103:11282-11287. (Pubitemid 44156510)
10. Komeima K, Rogers BS, Lu L, Campochiaro PA. 2006. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 103:11300-11305. (Pubitemid 44159928)
11. Kowluru RA, Chan P-S. 2007. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603-43614. (Pubitemid 46630110)
12. Kryzstolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NM, Li W, Connolly E, O'Neill CA, Miller JW. 2002. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338-346. (Pubitemid 34250056)
13. Kwak N, Okamoto N, Wood JM, Campochiaro PA. 2000. VEGF is an important stimulator in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158-3164.
14. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA. 2001. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253-263. (Pubitemid 32622916)
15. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA. 1997. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-291. (Pubitemid 27283979)
16. Okamoto A, Iwamoto Y, Maru Y. 2006. Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 26:108710-108797. (Pubitemid 43146500)
17. Oshima Y, Oshima S, Nambu H, Kachi S, Hackett SF, Melia M, Kaleko M, Connelly S, Esumi N, Zack DJ, Campochiaro PA. 2004. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol 201:393-400. (Pubitemid 39453125)
18. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS. 2006. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431. (Pubitemid 44511557)
19. Saishin Y, Saishin Y, Takahashi K, Lima Silva R, Hylton D, Rudge J, WS J, Campochiaro PA. 2003. VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:241-248. (Pubitemid 36384298)
20. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W. 1994. Dietary carotenoids, vitamins A,C, and E, and advanced macular degeneration. Eye Disease Case-Control Study Group. JAMA 272:1413-1420. (Pubitemid 24328383)
21. Shen J, Xie B, Dong A, Swaim M, Hackett SF, Campochiaro PA. 2007. In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels. Invest Ophthalmol Vis Sci 48:4335-4341.
22. Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111. (Pubitemid 24046832)
23. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA. 1998a. Evolution of neovascularization inmice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180-188. (Pubitemid 28040477)
24. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA. 1998b. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641-1646. (Pubitemid 28509922)
25. phox- containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91:1160-1167.
26. 2 via an antioxidant response element. FASEB J 19:2085-2087.
27. Yamato M, Matsumoto S, Ura K, Yamada K, Naganuma T, Inoguchi T, Watanab T, Utsumi H. 2007. Are free radical reactions increased in the diabetic eye. Antioxid Redox Signal 9:367-373. (Pubitemid 46145982)